CVRX Financials: Revenue & Earnings

CVRX price $1.32 -0.10 -6.71%

Ticker
CVRX
Price
$1.32
Change
-0.10 -6.71%
Market cap ?
$35.17M
P/E ?
-0.70
Dividend yield ?
0.00%
Beta ?
0.77
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
62
Value
58
Quality
46
Growth
81

Stocklytics score rationale: value 58, quality 46, growth 81.

Financials

2019202020212022202320242025
625700060530001303600022469000392950005129200056651000

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often…

Fair value

CVRX fair value Not meaningful. Price $1.32.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CVRX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.49—13.93M
2026-08-06-0.53-0.5215.71M15.55M
2026-05-11-0.50-0.5114.77M14.49M
2026-02-12-0.46-0.4216.02M15.78M
2025-11-05-0.49-0.5014.69M15.75M
2025-08-04-0.57-0.5213.59M14.40M
2025-05-08-0.53-0.5612.35M13.32M
2025-02-04-0.43-0.3715.34M15.22M
2024-10-29-0.57-0.4513.37M13.21M
2024-07-29-0.65-0.5111.81M11.79M
2024-04-30-1.04-0.5310.77M11.42M
2024-01-25-0.44-0.5511.30M11.14M
2023-10-26-0.43-0.5710.51M9.82M
2023-07-25-0.56-0.579.50M9.82M
2023-04-27-0.55-0.577.98M8.57M
2023-01-26-0.51-0.557.18M7.20M
2022-11-01-0.48-0.566.19M5.72M
2022-07-28-0.54-0.545.03M4.70M
2022-04-25-0.49-0.494.08M3.79M
2022-02-15-0.52-0.433.66M4.09M
2021-11-04-0.30-0.383.40M3.28M
2021-08-09-48.48-30.493.12M2.83M
2021-08-04-48.48-21.272.86M2.16M
2020-12-31-9.45—2.09M—
2020-09-30-8.96—997.00K—
2020-06-30-10.18—1.25M—
2020-03-31-8.13—1.72M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-13Binkowski BrentBuy26.22K$2.9176.43K
2026-08-12Binkowski BrentSell1.31K$2.553.34K
2026-06-01Nielsen Kirk G.Buy11.18K$5.4360.72K
2026-06-01Nielsen Kirk G.Buy8.72K——
2026-06-01Jain Mudit K.Buy8.72K——
2026-06-01Jain Mudit K.Buy11.18K$5.4360.72K
2026-06-01SLATTERY JOSEPH PBuy8.72K——
2026-06-01SLATTERY JOSEPH PBuy11.18K$5.4360.72K
2026-06-01Hill, Mitch C.Buy11.18K$5.4360.72K
2026-06-01Hill, Mitch C.Buy8.72K——
2026-06-01Ballinger Kevin J.Buy11.18K$5.4360.72K
2026-06-01Ballinger Kevin J.Buy8.72K——
2026-06-01SHADAN MARTHABuy11.18K$5.4360.72K
2026-06-01SHADAN MARTHABuy8.72K——
2026-06-01DALE MICHAEL DBuy36.25K$5.43196.85K
2026-06-01DALE MICHAEL DBuy29.00K——
2026-06-01DALE MICHAEL DOther0——
2026-03-02Adamson Philip B.Sell1.26K$7.909.97K
2026-03-02Morrison GregoryBuy154.50K$8.221.27M
2026-03-02Morrison GregoryBuy34.00K——
2026-03-02Morrison GregoryOther0——
2026-03-02Hykes KevinSell7.76K$7.9061.35K
2026-03-02VERRASTRO PAULSell1.28K$7.9010.15K
2026-03-02OASHEIM JAREDSell1.74K$7.9013.78K
2026-03-02John Robert AllenSell3.96K$7.9031.33K
2026-02-27Adamson Philip B.Buy41.00K——
2026-02-27Adamson Philip B.Buy62.00K$8.16505.92K
2026-02-27Hykes KevinBuy159.00K——
2026-02-27Hykes KevinBuy238.00K$8.161.94M
2026-02-27VERRASTRO PAULBuy67.00K$8.16546.72K
2026-02-27VERRASTRO PAULBuy45.00K——
2026-02-27OASHEIM JAREDBuy61.00K——
2026-02-27OASHEIM JAREDBuy91.00K$8.16742.56K
2026-02-27John Robert AllenBuy35.00K——
2026-02-27John Robert AllenBuy52.00K$8.16424.32K
2026-02-27Binkowski BrentBuy15.00K——
2026-02-27Binkowski BrentBuy23.00K$8.16187.68K
2026-02-20Jain Mudit K.Buy46.80K$6.36297.59K
2026-02-18Jain Mudit K.Buy600$4.642.79K
2025-11-26JOHNSON & JOHNSONSell6.34K$10.0363.56K
2025-11-26JOHNSON & JOHNSONSell6.34K$10.0363.56K
2025-11-25JOHNSON & JOHNSONSell16.00K$10.03160.48K
2025-11-24JOHNSON & JOHNSONSell2.20K$10.0622.13K
2025-11-21JOHNSON & JOHNSONSell500$10.005.00K
2025-11-12JOHNSON & JOHNSONSell1.00K$10.0010.00K
2025-11-07JOHNSON & JOHNSONSell200$10.002.00K
2025-11-06JOHNSON & JOHNSONSell52.33K$10.21534.31K
2025-08-11Binkowski BrentBuy74.90K$7.51562.50K
2025-08-11Binkowski BrentBuy16.60K——
2025-08-11Binkowski BrentOther0——
2025-06-03Nielsen Kirk G.Buy19.55K$6.76132.19K
2025-06-03Jain Mudit K.Buy19.55K$6.76132.19K
2025-06-03SLATTERY JOSEPH PBuy19.55K$6.76132.19K
2025-06-03Hill, Mitch C.Buy19.55K$6.76132.19K
2025-06-03Ballinger Kevin J.Buy19.55K$6.76132.19K
2025-06-03SHADAN MARTHABuy19.55K$6.76132.19K
2025-05-15Nielsen Kirk G.Buy10.97K$5.4559.80K
2025-05-14Nielsen Kirk G.Buy61.20K$5.23320.36K
2025-05-13Nielsen Kirk G.Buy101.41K$5.29536.31K
2025-05-13Jain Mudit K.Buy150$5.26789
2025-05-12Nielsen Kirk G.Buy25.20K$4.79120.67K
2025-05-12Jain Mudit K.Buy1.50K$4.666.99K
2025-05-12Hykes KevinBuy5.00K$4.8424.20K
2025-02-28Hykes KevinBuy148.00K$12.961.92M
2025-02-28Hykes KevinBuy98.00K——
2025-02-28John Robert AllenBuy55.00K——
2025-02-28John Robert AllenBuy38.00K$12.96492.48K
2025-02-28OASHEIM JAREDBuy22.00K——
2025-02-28OASHEIM JAREDBuy33.00K$12.96427.68K
2025-02-28Adamson Philip B.Buy30.00K$12.96388.80K
2025-02-28Adamson Philip B.Buy20.00K——
2025-02-28VERRASTRO PAULBuy24.00K$12.96311.04K
2025-02-28VERRASTRO PAULBuy16.00K——
2025-02-04Adamson Philip B.Other190.21K$7.821.49M
2024-11-21VERRASTRO PAULSell1.04K——
2024-11-19VERRASTRO PAULSell2.50K$5.1412.85K
2024-11-19VERRASTRO PAULBuy2.50K$5.1412.85K
2024-11-19VERRASTRO PAULSell1.43K$13.5819.42K
2024-09-03Ballinger Kevin J.Buy36.14K$9.05327.03K
2024-09-03Hill, Mitch C.Buy36.14K$9.05327.03K
2024-09-03Hill, Mitch C.Other0——
2024-09-03Ballinger Kevin J.Other0——
2024-08-15SLATTERY JOSEPH PBuy3.00K$8.1024.30K
2024-08-08SLATTERY JOSEPH PBuy3.00K$8.2424.72K
2024-08-06SLATTERY JOSEPH PBuy2.50K$9.0922.73K
2024-08-05Hykes KevinBuy30.00K$8.36250.77K
2024-07-31Hykes KevinBuy180.00K$8.551.54M
2024-06-27John Robert AllenBuy122.19K$11.701.43M
2024-06-27John Robert AllenOther0——
2024-06-04Behbahani AliBuy27.25K$6.49176.85K
2024-06-04Nielsen Kirk G.Buy27.25K$6.49176.85K
2024-06-04SLATTERY JOSEPH PBuy27.25K$6.49176.85K
2024-06-04Jain Mudit K.Buy27.25K$6.49176.85K
2024-06-04SHADAN MARTHABuy27.25K$6.49176.85K
2024-06-04Behbahani AliBuy20.96K$6.49136.04K
2024-06-04SLATTERY JOSEPH PBuy20.96K$6.49136.04K
2024-06-04Jain Mudit K.Buy20.96K$6.49136.04K
2024-06-04SHADAN MARTHABuy20.96K$6.49136.04K
2024-06-04Nielsen Kirk G.Buy20.96K$6.49136.04K
2024-03-25Palmer Craig E.Buy151$0.2436

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 92, holders -9 vs prior quarter. Ownership 58.16%.

HolderSharesChangeChange %Value
JOHNSON & JOHNSON4.02M00.00%20.69M
NEA MANAGEMENT COMPANY, LLC1.95M-71.64K-3.54%10.05M
BLACKROCK, INC.1.25M218.90K+21.32%6.40M
ROYAL BANK OF CANADA1.23M526.26K+74.44%6.34M
GSK PLC1.01M00.00%5.18M
VANGUARD CAPITAL MANAGEMENT LLC910.58K-734-0.08%4.68M
SILVERCREST ASSET MANAGEMENT GROUP LLC878.11K306.09K+53.51%4.51M
GEODE CAPITAL MANAGEMENT, LLC440.79K13.71K+3.21%2.27M
PFM HEALTH SCIENCES, LP369.57K369.57KNew1.90M
STATE STREET CORP366.35K15.80K+4.51%1.88M
RENAISSANCE TECHNOLOGIES LLC230.00K210.70K+1091.71%1.18M
UBS GROUP AG224.23K120.42K+116.00%1.15M
TUDOR INVESTMENT CORP ET AL205.68K8.34K+4.23%1.06M
GOLDMAN SACHS GROUP INC149.51K-51.50K-25.62%768.48K
MORGAN STANLEY144.98K5.61K+4.03%745.18K
KESTRA ADVISORY SERVICES, LLC132.40K84.50K+176.41%680.54K
TWO SIGMA INVESTMENTS, LP132.40K18.23K+15.97%680.53K
VANGUARD FIDUCIARY TRUST CO128.96K1.19K+0.93%662.83K
DIMENSIONAL FUND ADVISORS LP127.97K75.33K+143.10%659.87K
NORTHERN TRUST CORP124.77K-25.36K-16.89%641.30K
VANGUARD PORTFOLIO MANAGEMENT LLC105.92K11.07K+11.67%544.40K
AQR CAPITAL MANAGEMENT LLC105.61K15.71K+17.47%542.86K
CRESSET ASSET MANAGEMENT, LLC103.85K-2.50K-2.35%533.78K
BNP PARIBAS FINANCIAL MARKETS97.31K-1.36K-1.38%500.17K
QUANTINNO CAPITAL MANAGEMENT LP82.33K-33.48K-28.91%423.19K

Earnings and financials

CVRx, Inc. (CVRX) trades at $1.32, with a market cap of $35.17M and a trailing P/E of -0.70. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
625700060530001303600022469000392950005129200056651000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

CVRX Financials: Revenue & Earnings

CVRX$1.32-0.10 -6.71%

$35.17M

Market Cap

-0.70

P/E

—

Forward P/E

62

Score

Price History